The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. The metric has seen a significant gain of 0.57% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -12.47%. Over the past 30 days, the price of NVS has leaped by -0.51%. And in the last five days, it has fallen by -2.35%.
Novartis AG ADR’s stock market performance has been somewhat irregular. The 1-year high for the company’s stock was recorded at $120.92 on 08/30/24, with the lowest value being $92.35 on 04/18/24.
52-week price history of NVS Stock
A stock’s 52-week price history, including the low and high prices, can offer valuable insights into its current standing and future prospects. Novartis AG ADR’s current trading price is -19.07% away from its 52-week high, while its distance from the 52-week low is 5.97%. The stock’s price range over this timeframe has been between $92.35 and $120.92. The shares of the Healthcare sector company recorded a trading volume of approximately 3.11 million for the day, which was comparatively higher than the average daily volume of 1.2 million over the last three months.
The Connection Between Financial Performance and Market Capitalization
Novartis AG ADR (NVS) has experienced a quarterly decline of -15.80% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 191.46B and boasts a workforce of 76057 employees.
How Moving Averages and Trading Volume Data Work Together
Based on Barchart.com data, the company’s moving average over the 100-day period was 108.58, with a change in price of -19.90. Similarly, Novartis AG ADR recorded 1,145,537 in trading volume during the last 100 days, posting a change of -16.90%.
NVS’s Debt-to-Equity Ratio: A Comprehensive Review
A key metric for assessing a company’s financial well-being and market status is the debt-to-equity (D/E) ratio. This ratio is derived by dividing a company’s total liabilities by its shareholders’ equity, and it demonstrates the level of debt a company uses to support its assets relative to shareholder equity. At the time of writing, the total D/E ratio for NVS stands at 0.74. Similarly, the long-term debt-to-equity ratio is also 0.59.
NVS Stock Stochastic Average
Novartis AG ADR’s raw stochastic average for the past 50 days is currently at 11.85%. This represents a fall from the raw stochastic average of the last 20 days, which was recorded at 39.02%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 58.70% and 65.52%, respectively.
